Daiichi Sankyo
Kara Reheis has a diverse work experience spanning multiple roles and companies. Kara began their career as a Leadership Development Associate at Cardinal Health in 2002 and later joined GlaxoSmithKline as a Sales Representative in 2005. In 2007, they transitioned to a role at Daiichi Sankyo, Inc. where they held various positions over the years. Kara'sroles at Daiichi Sankyo include Senior Analyst, Market Planning; Senior Product Manager, Hypertension Franchise; Brand Director, Hypertension Franchise; Director, Payer Marketing; Region Director; Sr Director, Strategic Planning & Operations; Executive Director, Commercial Operations; and Vice President, Commercial Operations. Currently, Kara holds the position of Vice President, Marketing at Daiichi Sankyo, Inc.
Kara Reheis holds an MBA degree from Villanova University, which they obtained from 2003 to 2006. Kara also pursued a Master of Business Administration (MBA) degree at Rutgers University - Newark from 2005 to 2006. Prior to that, they completed their undergraduate studies at the University of Scranton, where they earned a Bachelor of Science (B.S.) degree in Marketing from 1999 to 2002.
This person is not in any offices
Daiichi Sankyo
21 followers
Daiichi Sankyo Co., Ltd. engages in the research, development, manufacture, and sale of pharmaceutical products. It operates through the following segments: Daiichi Sankyo Group and Ranbaxy Group. The Daiichi Sankyo Group segment comprises of Daiichi Sankyo Co., Ltd. and its subsidiaries. The Ranbaxy Group segment includes its core company, Ranbaxy Laboratories Ltd. Both group segments deal with business activities in prescription drugs and general pharmaceutical products. The company was founded on September 28, 2005 and is headquartered in Tokyo, Japan.